fbpx

Gadovist


Bayer
|
Gadovist

gadovist

Bayer

Gadovist

The most widely used MRI contrast agent in the world.

29 million applications confirm this.

Extracellular contrast agent of the macrocyclic class, with the highest stability.

6,800 patients evaluated in prospective studies during the clinical development program.

Safety of Gabutrol: Results of 42 phase II to phase IV clinical studies and post-marketing surveillance after 29 million applications. Invest Radiol.

Low rate of adverse drug reactions (ADR) of o7%.

Safety of Gadobutrol in over 23,000 patients: the GUARDIAN study, a global multicenter, prospective, non-interventional study, Eur Radiol 2017:27 (1):286-295.